Loading clinical trials...
Loading clinical trials...
Single Dose Crossover Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Film-coated Tablets in Healthy Male and Female Volunteers.
Conditions
Interventions
Sitagliptin/Metformin HCl 50/850 mg film-coated tablet
Locations
1
Canada
Algorithme Pharma
Mount Royal, Quebec, Canada
Start Date
October 22, 2017
Primary Completion Date
November 1, 2017
Completion Date
November 1, 2017
Last Updated
September 22, 2022
NCT06959901
NCT06574035
NCT06861062
NCT07336329
NCT04583800
NCT06251323
Lead Sponsor
Galenicum Health
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions